ArticleFrontiers in oncology2023

Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project.

Marina Elena Cazzaniga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.